Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | CMV-CD19 CAR T-cells |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
CMV-CD19 CAR T-cells are CMV-specific T-cells that are engineered to express a chimeric antigen receptor (CAR) targeting CD19, which may stimulate an anti-tumor response against CD19-expressing tumors (PMID: 35027426, PMID: 25838392). |
| DrugClasses | CD19 Immune Cell Therapy 72 |
| CAS Registry Number | NA |
| NCIT ID | C187649 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| CMV-CD19 CAR T-cells | CMV-CD19 CAR T-cells | 0 | 1 |
| CMV-CD19 CAR T-cells + Multi-antigen CMV-modified vaccinia Ankara vaccine | CMV-CD19 CAR T-cells Multi-antigen CMV-modified vaccinia Ankara vaccine | 0 | 2 |